Author Interviews

13 Jan

Posted at 13:06h in Author Interviews
routine-foot-care.jpg   Foot pain or dry, cracked heels often disrupt comfort and daily routines. Neglecting foot health can lead to discomfort, infections, and long-term issues. These challenges affect mobility and reduce overall well-being, especially without consistent care. Common foot problems often go unnoticed, worsening over time.   Routine foot care by a foot specialist plays a critical role in improving foot health and preventing serious issues. Regular preventive maintenance helps avoid infections, reduces discomfort, and promotes better mobility. It contributes significantly to overall health and ensures long-lasting comfort in daily activities.   This article offers practical insights into routine foot care for maintaining healthy feet. Simple, consistent care practices can prevent common problems and enhance foot health for all individuals.

08 Jan

Posted at 11:49h in Alzheimer's - Dementia, Author Interviews, Herpes Viruses
MedicalResearch.com Interview with: [caption id="attachment_65850" align="alignleft" width="150"]Dr. Or Shemesh PhDThe Harvey M. Krueger Family Center for Center for Nanoscience and Nanotechnology School of Pharmacy - Institute for Drug Research The Hebrew University of Jerusalem Dr. Or Shemesh[/caption] Dr. Or Shemesh PhD The Harvey M. Krueger Family Center for Center for Nanoscience and Nanotechnology School of Pharmacy - Institute for Drug Research The Hebrew University of Jerusalem MedicalResearch.com: What is the background for this study? Response: Our study investigated the connection between herpes simplex virus 1 (HSV-1) and Alzheimer's disease (AD) pathologies. We explored how HSV-1 proteins are present in the brains of individuals with AD and examined their interactions with tau, a key protein in AD pathology. MedicalResearch.com: What are the main findings? Response:  The main finding is that tau, traditionally seen as detrimental, might initially act as a protective response to HSV-1 by reducing neuronal death through an antiviral innate immunity pathway called cGAS-STING . Over time, this (initially beneficial) antiviral response of tau can manifest as the well established tau toxicity in Alzheimer's disease.

08 Jan

Posted at 07:12h in Author Interviews, Disability Research, Pediatrics
Author Bio: Lorraine Culpo is a dedicated writer with a focus on healthcare, disability advocacy, and family well-being. With a passion for shedding light on the importance of early pediatric support, she aims to empower readers with insights into how comprehensive care can shape brighter futures for children with disabilities. pediatric-care-academic-support.jpg Pediatric care plays an essential role in helping children grow and develop, especially those living with disabilities. Through early support, medical care, and learning resources, pediatric care improves children’s outcomes and builds a foundation for a more inclusive society. Understanding how pediatric care shapes disability support can help families, educators, and healthcare providers create an environment where every child can thrive.

Early Support Changes Lives

Early support services can make a big difference for children with disabilities. When doctors and specialists spot developmental challenges early, children can get help sooner. This early start allows them to build important skills at key stages of growth. For example, speech therapy can help a child with delayed language skills improve their ability to communicate. Physical therapy can help children with motor challenges gain strength and coordination. These interventions work best when they begin as early as possible, which increases the chances that children will meet milestones that lead to more independence. In many cases, NDIS treatment plans for children ensure that the support they receive is tailored to their specific developmental and medical requirements. It provides a structured approach that aligns with their long-term goals.

02 Jan

Posted at 23:28h in Author Interviews
Please note: Supplements are generally not FDA tested or approved. Some supplements can interfere with medications and/or cause side effects. Do not delay seeking medical attention for medical concerns by taking supplements without medical advice. Please discuss any and all supplements you take with your health care provider and be sure to follow your provider’s recommendations for your prostate and overall health. Supplements should not be given to children, breast feeding or pregnant women without the specific advice or your medical provider.   [caption id="attachment_65779" align="aligncenter" width="500"]How to Keep Your Immune System Strong Image source[/caption] Have you ever felt like you’re constantly battling colds or other illnesses? Whether it’s the flu season, allergy season, or just the daily grind, your immune system works hard to keep you healthy. Your immune system is your body’s defense system, protecting you from harmful germs, bacteria, and viruses. A strong immune system helps you recover quickly, while a weak one leaves you feeling run-down. Keeping your immune system strong year-round isn’t about quick fixes. It’s about forming healthy habits and giving your body the support it needs. By making smart choices with your diet, lifestyle, and stress management, you can boost your immune health and feel your best. In this blog, we will share practical ways to support your immune system and stay healthy throughout the year.

Eat a Balanced and Nutrient-Rich Diet

If you want a stronger immune system, start with what’s on your plate. Your body needs vitamins, minerals, and nutrients to fight off illness. Focus on adding more fruits, vegetables, whole grains, lean proteins, and healthy fats to your meals. Foods like citrus fruits, berries, spinach, nuts, and chicken give you key nutrients like vitamins C, D, and E, plus zinc. These help keep your body ready to defend you. Eating a balanced diet doesn’t have to be complicated—stick to simple, whole foods, and your body will thank you.

Support Your Gut Health

A large part of your immune function is located in your digestive tract. When your gut is healthy, your body can better fight off harmful invaders. Probiotics, prebiotics, and supplements that support your gut lining can help maintain a healthy immune system. Using supplements like Mega Mucosa can help support a healthy mucosal barrier, which is essential for strong immune defenses. This supplement contains ingredients that promote microbial diversity and help maintain the gut lining. At places like Lakeland Drug Company, you can find products designed to give your immune system the support it needs. They provide trusted options to help you care for your immune health year-round.

01 Jan

Posted at 11:37h in Author Interviews, Technology
advancing field medicine Field medicine has changed greatly over the years. The focus has been on creating faster, more efficient, and easier-to-use healthcare tools. Portable medical systems are especially important because they help provide immediate care during emergencies, natural disasters, and military operations. These advancements are making a big difference in how healthcare professionals handle challenges in remote areas for tactical combat casualty care. Portable systems are improving response times and saving lives. This article looks at some of the key innovations and what they mean for the future.

Why Portable Medical Systems Matter

In emergencies, having portable medical devices can save lives. Lightweight and compact equipment allows healthcare teams to reach places where traditional machines cannot go. These tools ensure that doctors and nurses can deliver care even in remote locations or areas with little infrastructure. Portable ultrasound machines, for instance, help healthcare workers see real-time images of injuries or conditions without needing a hospital setting. In emergency zones, an army medical tent equipped with these devices can serve as a lifesaving center and help provide rapid assessments and care. Similarly, handheld ECG devices let providers monitor heart activity during transport. These tools are not only smaller but also built to last in tough environments.

29 Dec

Posted at 14:02h in Author Interviews, Nutrition, Prostate Cancer
[caption id="attachment_65733" align="alignleft" width="201"]By Dr. Dan Sperling M.D., D.A.B.R.sMedical Director and Chief of Interventional Uroradiology at the Sperling Prostate Center in Florida Medical Director of its parent practice, the Sperling Medical Group Dr. Sperling[/caption] By Dr. Dan Sperling M.D., D.A.B.R. Medical Director and Chief of Interventional Uroradiology at the Sperling Prostate Center in Florida Medical Director of its parent practice, the Sperling Medical Group If the name Dr. Dean Ornish rings a bell, it’s probably because over 30 years ago he became the poster boy for preventing heart disease through diet and exercise. His 1990 book, “Dr. Dean Ornish's Program for Reversing Heart Disease,” made the NYTimes best seller list. To this day, when we think of Dr. Ornish, we think of a long and heart-healthy life. Although we don’t link Dr. Ornish with prostate health, there’s good reason to do so—but most men don’t know it. In 2008, the National Academy of Sciences published research  by Dr. Ornish and his team in an article titled “Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention.” They broke new ground in our understanding of preventing prostate cancer (PCa). Dr. Ornish and his team showed that a comprehensive lifestyle program they designed actually caused changes in gene regulation. They designed an experimental lifestyle protocol and tested is on 30 PCa patients; all 30 had been diagnosed with low-risk PCa and were on Active Surveillance (no other treatment). At the start of the 3-month study, each patient’s biopsy samples were used to profile his PCa gene activity. Then all participants adhered faithfully to the following protocol:
  • A vegan (plant-based) diet (with 10% of calories from fat
  • Physical activity (walking 30 minutes a day for 6 days a week)
  • Stress reduction (yoga, progressive relaxation, breathing, meditation)
  • Dietary supplements (vitamins C and E, soy, fish oil, selenium)
  • A weekly support group to provide advice and sustain adherence to the program.

26 Dec

Posted at 14:02h in Author Interviews
[caption id="attachment_65691" align="aligncenter" width="500"]wearable-technologies Image Source[/caption] Chronic illness management has grown easier due to technological developments and inventive treatments. From wearable gadgets to real-time health tracking, technology is changing the way patients receive treatment. These advancements enable people to monitor and control their health proactively from home. As healthcare providers adopt these tools, patient outcomes improve, and the burden on facilities decreases. With a focus on seamless communication, digital health tools foster stronger doctor-patient relationships.  In this article, we will explore how technology is revolutionizing chronic disease management, focusing on its practical applications and benefits. Let’s discuss five key ways technology is driving change.

24 Dec

Posted at 23:17h in Author Interviews, Cancer Research, Lymphoma, Nutrition, University of Pennsylvania
MedicalResearch.com Interview with: [caption id="attachment_65650" align="alignleft" width="200"]Shan Liu, PhD, Postdoctoral fellowPerelman School of Medicine University of Pennsylvania Dr. Shan Liu[/caption] Shan Liu, PhD, Postdoctoral fellow Perelman School of Medicine University of Pennsylvania MedicalResearch.com: What is the background for this study? Response: Our study provides evidence that the efficacy of CAR T cell immunotherapies can be influenced by an important lifestyle factor: diet.   MedicalResearch.com: What are the main findings? Response:  Our study found that a ketogenic diet can enhance CAR T cell function through its metabolite, β-Hydroxybutyrate (BHB). Importantly, instead of altering the diet, providing BHB via oral supplementation in our preclinical model is sufficient to improve the anti-tumor function of CAR T cells. However, it's important to note that we’re still in the early stages, and we’re not yet recommending any dietary changes or supplements for patients.

17 Dec

Posted at 16:25h in Author Interviews, Clots - Coagulation, Environmental Risks
MedicalResearch.com Interview with: [caption id="attachment_65560" align="alignleft" width="200"]Pamela L Lutsey PhD, MPHProfessor, Division of Epidemiology & Community Health University of Minnesota Minneapolis, Minnesota Dr. Lutsey[/caption] Pamela L Lutsey PhD, MPH Professor, Division of Epidemiology & Community Health University of Minnesota Minneapolis, Minnesota MedicalResearch.com: What is the background for this study? Response: Air pollution is ubiquitous. In order to understand the impact of exposure on health, it is necessary to look across diverse health conditions. Associations with lung disease and atherosclerotic cardiovascular disease are more established. Less is known about the role of air pollution exposure on coagulation and venous thromboembolism (VTE). MedicalResearch.com: Are individuals less ambulatory in heavily polluted areas? The study did not address this question directly. The association did persist across a wide range of subgroups of the sample, including those who were not smokers and who had no evidence of lung disease.

16 Dec

Posted at 19:09h in Author Interviews, Cancer Research, Exercise - Fitness, Hematology
MedicalResearch.com Interview with: [caption id="attachment_65529" align="alignleft" width="200"]Janine Joseph, MS, MBASenior Research Specialist Cancer Prevention & Control Roswell Park Comprehensive Cancer Center Buffalo, NY Janine Joseph, MS[/caption] Janine Joseph, MS, MBA Senior Research Specialist Cancer Prevention & Control Roswell Park Comprehensive Cancer Center Buffalo, NY MedicalResearch.com: What is the background for this study? Response: Due to improvements in treatments, patients with multiple myeloma (MM) are experiencing longer lifespans and seeking ways to enhance their quality-of-life.  Fatigue, pain and negative psychological states such as anxiety and depression are common in cancer patients, including patients with MM.  Pain is particularly relevant, as MM can cause painful osteolytic (bone) lesions. The trials we discussed at ASH were aimed at evaluating the effect of exercise, specifically supervised resistance training and unsupervised walking exercise, on these and other states, including physical function and immune profile.

11 Dec

Posted at 20:40h in Alzheimer's - Dementia, Author Interviews, Biomarkers
MedicalResearch.com Interview with: [caption id="attachment_65442" align="alignleft" width="180"]Alberto J. Espay, MD, MSc, FAANProfessor of Neurology Director and Endowed Chair Gardner Family Center for Parkinson's disease and Movement Disorders University of Cincinnati Academic Health Center Prof. Espay[/caption] Alberto J. Espay, MD, MSc, FAAN Professor of Neurology Director and Endowed Chair Gardner Family Center for Parkinson's disease and Movement Disorders University of Cincinnati Academic Health Center MedicalResearch.com: What is the background for this study? What are the main findings Response:  Because aducanumab, lecanemab, and donanemab were only in a minority of anti-amyloid treatments showing a benefit, I was interested in finding out what makes them special. It turns out that they not only clean the brain from amyloid, like other monoclonal anti-Aβ antibodies, but they also increase Aβ42 in the spinal fluid, which is a measure of the normal protein in the brain. Everyone with Alzheimer’s has low Aβ42 levels because this protein clumps into amyloid plaques. I tested the hypothesis that increasing Aβ42 could explain the cognitive outcomes at least as well as decreasing amyloid, and that’s exactly what we found. This suggests that restoring the normal protein levels, Aβ42, may explain why some anti-amyloid treatments (presumably those that increased those levels the most) come with benefits.

05 Dec

Posted at 13:54h in Author Interviews, Medical Imaging
MedicalResearch.com Interview with: [caption id="attachment_65254" align="alignleft" width="225"]Miriam A. Bredella, MD, MBABernard and Irene Schwartz Professor of Radiology & Vice Chair for Strategy Associate Dean for Translational Science Director, Clinical and Translational Science Institute NYU Grossman School of Medicine NYU Langone Health Translational Research Building 743 New York, NY 10016 Dr. Bredella[/caption] Miriam A. Bredella, MD, MBA Bernard and Irene Schwartz Professor of Radiology & Vice Chair for Strategy Associate Dean for Translational Science Director, Clinical and Translational Science Institute NYU Grossman School of Medicine NYU Langone Health Translational Research Building 743 New York, NY 10016   MedicalResearch.com: What is the background for this study? Response: We perform >80 million CTs every year in the US, and there is a lot of information on these CTs that is not used and “thrown away.” Opportunistic imaging or opportunistic screening with the help of AI takes advantage of this information and automatically detects and quantifies vascular calcification, bone mineral density, abdominal fat or muscle mass. In our study, we wanted to detect whether calcification of the abdominal aorta, quantified using AI, could predict coronary artery calcification and major cardiovascular events (e.g. myocardial infarction, cardiac revascularization, stroke, or death).

05 Dec

Posted at 13:44h in Author Interviews, Cancer Research, NEJM, NIH, OBGYNE
MedicalResearch.com Interview with: [caption id="attachment_65321" align="alignleft" width="92"]Diana W. Bianchi, M.D.Senior Investigator Center for Precision Health Research Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health Dr. Bianchi[/caption] Diana W. Bianchi, M.D. Senior Investigator Center for Precision Health Research Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health MedicalResearch.com: What is the background for this study? Response: The ability of prenatal cell-free DNA (cfDNA) sequencing to incidentally detect maternal cancers has been demonstrated by several retrospective studies from commercial or national laboratories. However, there are no standardized approaches to the identification and medical management of prenatal screening results that might indicate a maternal cancer. We sought to prospectively identify DNA sequencing patterns and other biomarkers that could distinguish which women with nonreportable or unusual cfDNA sequencing results had cancer and to determine the best approach for diagnostic work-up of pregnant people who receive these results.

04 Dec

Posted at 03:40h in Author Interviews, OBGYNE
MedicalResearch.com Interview with: John W. AyersJohn W. Ayers, PhD, MA Altman Clinical Translational Research Institute University of California San Diego, La Jolla MedicalResearch.com: What is the background for this study? Response: Crisis pregnancy centers (CPCs) are frequently at the center of news and policy debates, yet little data exists about where they operate or what they actually do. To address this gap, we developed ChoiceWatch.org, a tool that systematically collected and analyzed over 470,000 webpages from CPC websites. In our study published in JAMA Internal Medicine, we used ChoiceWatch.org, to answer fundamental questions, such as how many crisis pregnancy centers operate in the U.S., where they are located, and what services they advertise.

30 Nov

Posted at 20:08h in Author Interviews, COVID -19 Coronavirus, Mental Health Research, Pulmonary Disease
MedicalResearch.com Interview with: [caption id="attachment_65216" align="alignleft" width="200"]Sean B. Fain, Ph.D.Professor and  Vice Chair for Research Department of Radiology Affiliate Appointments BME and ECE University of Iowa Iowa City, IA Dr. Fain[/caption] Sean B. Fain, Ph.D. Professor and Vice Chair for Research Department of Radiology Affiliate Appointments BME and ECE University of Iowa Iowa City, IA MedicalResearch.com: What is the background for this study? Response: This study uses MRI to investigate connections between lung and brain function. We employ an advanced MRI technique that uses hyperpolarized xenon gas as a contrast agent. This approach allows us to image which parts of the lung are effectively inhaling xenon gas and which parts are not (i.e. ventilation). Additionally, xenon provides insights into lung gas exchange (i.e. oxygen transfer into and out of the blood), as it freely diffuses into alveolar tissue and binds to red blood cells. Using this technology, we hypothesized that the severity of lung injury in individuals with Long COVID would correlate with the degree of cognitive dysfunction and brain imaging.

29 Nov

Posted at 11:21h in addiction-treatment, Alcohol, Author Interviews
For Emergency assistance with mental health or addiction crisis please go to: https://www.samhsa.gov/find-help/national-helpline [caption id="attachment_65187" align="aligncenter" width="500"]alcohol-addiction-roots Photo by Isabella Mendes[/caption] Alcohol addiction, or alcohol use disorder (AUD), remains a pervasive global issue, affecting millions of lives. The World Health Organisation (WHO) reports that alcohol abuse contributes to over 3 million deaths annually, making it one of the leading preventable causes of death worldwide. Understanding the root causes of alcohol addiction is crucial - not merely for academic purposes but for developing effective prevention strategies and treatment approaches. Experts and researchers have proposed multiple theories to explain the onset of addiction, ranging from biological predispositions to sociocultural influences, each offering unique insights into why addiction develops. This article will explore key theoretical models, their underlying frameworks, and their contributions to our understanding of alcohol addiction. Additionally, it will address emerging research, critiques of existing theories, and their practical application in addiction treatment.

28 Nov

Posted at 13:24h in Author Interviews, Protein, Weight Research
  [caption id="attachment_65178" align="aligncenter" width="500"]eggs-protein-eggwhites Photo by Felicity Tai[/caption]   Protein is a fundamental nutrient that plays a vital role in weight loss and appetite regulation. Understanding how protein affects these areas can help optimize dietary strategies for better health outcomes. From influencing hunger hormones to boosting metabolism, protein’s role in the body is multifaceted and powerful.

How Protein Influences Appetite

One of protein’s standout benefits is its ability to enhance feelings of fullness, also known as satiety. When you consume protein-rich foods, your body releases appetite-suppressing hormones such as peptide YY and GLP-1, which signal your brain to reduce hunger. In contrast, diets low in protein may leave individuals feeling hungrier, leading to overeating or increased snacking. This is why many weight loss programs emphasize incorporating high-protein meals and snacks to curb cravings and improve adherence to calorie-controlled plans.

27 Nov

Posted at 18:58h in Author Interviews, Orthopedics, Surgical Research
Anterior Cervical Discectomy Surgery While anterior cervical discectomy surgery has become a widely accepted and frequently performed procedure to relieve spinal cord or nerve root compression, it is not without potential risks and complications. These can range from common surgical risks, such as infection, to more procedure-specific complications like nerve damage, dural tears, and the possibility of recurrent disc herniation. As there is a critical need for increased awareness and understanding of these challenges, it is essential to engage in a thorough exploration of the potential outcomes and their management tactics.

Understanding Anterior Cervical Discectomy

The anterior cervical discectomy is a surgical procedure that warrants comprehension due to its complex nature. This surgical technique involves the removal of an intervertebral disc or a portion of this disc from the neck area, specifically in the anterior cervical spine. It is typically performed to alleviate spinal cord or nerve root pressure, leading to considerable pain relief and functional improvement. The procedure is often paired with a fusion to stabilize the spine. The recovery timeline varies for each individual depending upon factors like age, overall health status, and the severity of the disc problem. However, the immediate postoperative recovery period typically lasts for a few hours to a few days, during which time patients are closely monitored. Subsequent recovery, involving physical therapy and gradual return to normal activities, can stretch from several weeks to a few months. Though the anterior cervical discectomy is generally regarded as a safe and effective procedure, it is not devoid of risks. Potential complications include infection, nerve damage, difficulties swallowing or speaking, and issues related to the graft or hardware used in fusion. The understanding of these risks is paramount for patients undergoing this procedure.

22 Nov

Posted at 14:21h in Author Interviews, Cannabis, JAMA, Mental Health Research
MedicalResearch.com Interview with: [caption id="attachment_64963" align="alignleft" width="200"]Belén Blasco Belén Blasco[/caption] Belén Blasco PhD Student in Neuroscience - MD Psychiatry Clinical and Translational Sciences (CaTS) Lab Integrated Program in Neuroscience McGill University | Douglas Research Centre Montreal, Canada MedicalResearch.com: What is the background for this study? Response: Our research is centered on uncovering the early brain changes that might contribute to psychosis development. Using innovative brain imaging techniques, we aimed to measure synapsis in individuals with early psychotic symptoms or who are considered at high clinical risk. Synapses are the crucial points of connection between neurons, allowing communication across the brain. A key aspect of our study was to understand how lifestyle factors, like cannabis use, might impact these brain changes, particularly since cannabis consumption has been associated with an increased risk of developing psychosis in young people.

20 Nov

Posted at 10:04h in Author Interviews, Orthopedics, Pain Research, Surgical Research
Discussion and Explanation of Minimally Invasive Spine Surgery by: [caption id="attachment_64852" align="alignleft" width="200"]dr_brent-felix-md Dr. Brent Felix[/caption] Brent A. Felix, M.D Spine Surgery, Bone & Joint Surgery Salt Lake Orthopaedic Clinic Suite 4050 Salt Lake City, UT 84124 and Alpine Orthopaedic Specialists North Logan, UT 8434  

Minimally invasive spine surgery (MISS) has become a game changer in orthopedic surgery, offering patients safer and less painful options for treating spinal issues. Dr. Brent Felix, a leading orthopedic spine surgeon, is at the forefront of this movement, advocating for these innovative techniques that provide multiple benefits over traditional methods.

What Is Minimally Invasive Spine Surgery?

Minimally invasive spine surgery, or MISS, is a technique that allows surgeons to address spine conditions with much smaller incisions compared to traditional surgery. Rather than making large cuts to access the spine, Dr. Felix and his team use special instruments and imaging tools to perform surgery through small incisions. These tools include tiny cameras or endoscopes, which provide a clear view of the spine without the need for large openings.

12 Nov

Posted at 19:02h in Author Interviews, Genetic Research, Leukemia, Personalized Medicine
MedicalResearch.com Interview with: [caption id="attachment_64714" align="alignleft" width="125"]Professor Ong Sin TiongCancer & Stem Cell Biology Signature Research Programme Duke-NUS Medical School, Singapore Prof. Ong Sin Tiong[/caption] Professor Ong Sin Tiong Cancer & Stem Cell Biology Signature Research Programme Duke-NUS Medical School, Singapore [caption id="attachment_64743" align="alignleft" width="125"]Dr. Yu Mengge Dr. Yu Mengge[/caption] Dr Yu Mengge Research Fellow, Cancer & Stem Cell Biology Signature Research Programme Duke-NUS Medical School MedicalResearch.com: What is the background for this study? Response: The background of this study is rooted in the observation that certain genetic variations among East Asian populations, notably the BIM deletion polymorphism (BDP), impact treatment outcomes in chronic myeloid leukaemia (CML). Patients with the BDP show resistance to conventional treatments, specifically tyrosine kinase inhibitors like imatinib. This resistance stems from the variant's role in promoting cancer cell survival, which leads to more aggressive disease progression.

12 Nov

Posted at 14:11h in Author Interviews, Pharmacology
medical medicine box You might have noticed the key details mentioned on medical medicine boxes whenever you pick them up from a pharmacy. Information, precautions, symbols, and brand details mentioned on these boxes are important for individuals who are going to consume these medicines. Custom medicine boxes thus serve as an effective means of conveying the desired insights to the exact audience who is going to benefit from the relevant medicines for curing their specific health issues. Brands make sure to keep the details mentioned on medical medicine boxes highly relevant and assure the safety of individuals at all times while keeping them informed of the right dose of the medicine they are going to consume. This post explores how important are these custom packaging solutions for your pharmaceutical brand and what are the key features of medical medicine boxes.

08 Nov

Posted at 11:55h in Author Interviews, Lyme
  [caption id="attachment_64663" align="aligncenter" width="500"]tick lyme disease Source[/caption]   Own a dog? Then your vet must have shared a thing or two about the risks of ticks and even warned you about Lyme disease.  But is your furry friend only at risk of this bacterial infection? You’re wrong if you think so. Humans can also get Lyme disease if a black-legged tick carrying the borrelia bacteria bites them. Just recently, the comedian and actress Miranda Hart opened up about how she struggled with chronic fatigue syndrome after she was diagnosed with Lyme disease.  Many other famous people say they have been struck by this tick-borne bacterial infection. Those include Real Housewives of Beverly Hills star Yolanda Hadid and her daughter, model Bella Hadid, comic Amy Schumer, actor Ben Stiller, and singer Justin Bieber.  As high-profile names share their struggles, awareness of Lyme is spreading fast. But so are the myths. So, let’s separate the facts from the fiction surrounding this disease.

Myth #1: Lyme Disease Is Only a Problem in the Northeast

The Northeast does see a lot of Lyme disease cases, and that is mainly because it has a high population of black-legged ticks. But it is not confined to New England.   Lyme-carrying ticks can be found across much of the United States, especially in the upper Midwest and along the West Coast. In 2022, the largest number of Lyme disease cases were reported in the Middle Atlantic region—New Jersey, Pennsylvania, and New York.  There has also been a rapid surge in the number of cases in the northern New England states of New Hampshire, Vermont, and Maine, reports Mount Sinai.  So, why the misconception? Part of it comes down to awareness—doctors in the Northeast are more used to spotting it, which can lead to better diagnosis rates. Meanwhile, in other areas, this bacterial infection might be misdiagnosed or underreported, which is why it flies under the radar. 

06 Nov

Posted at 21:39h in Author Interviews, Neurology, Sexual Health, STD
MedicalResearch.com Interview with: [caption id="attachment_64639" align="alignleft" width="200"]Sagar S. Patel, MBSDepartment of Medical Education Geisinger Commonwealth School of Medicine Scranton, PA 18509 Sagar Patel[/caption] Sagar S. Patel, MBS Department of Medical Education Geisinger Commonwealth School of Medicine Scranton, PA 18509 MedicalResearch.com: What was the background for this research? Response: Syphilis is a sexually transmitted infection that is caused by a gram-negative bacterium called Treponema pallidum. This infection promotes the cell death of microglia and can cause a variety of symptoms. It is commonly observed in developing countries such as sub-Saharan Africa. Neurosyphilis is a complication of syphilis that affects the central nervous system (CNS). The CNS undergoes multiple stages of deterioration and can include personality changes and hearing abnormalities. Diagnosing neurosyphilis is challenging because its symptoms mimic other neurodegenerative diseases. Diagnosis relies on clinical studies, cerebrospinal fluid (CSF) analysis, and neuroimaging techniques.

06 Nov

Posted at 20:49h in AI and HealthCare, Author Interviews, Breast Cancer, Genetic Research
MedicalResearch.com Interview with: [caption id="attachment_64635" align="alignleft" width="150"]Prof. Dina Schneidman-Duhovny PhDAcademic researcher Hebrew University of Jerusalem Prof. Schneidman[/caption] Prof. Dina Schneidman-Duhovny PhD Academic researcher Hebrew University of Jerusalem MedicalResearch.com: What is the background for this study? What are the main findings? Response: The study analyzed genetic data of 12 families (~ 40 patients) with high incidence of breast cancer cases. Most families originate from ethnic groups that are poorly represented in public resources. All participants were tested negative to all known breast cancer predisposing genes. We developed a novel approach to study genetic variants utilizing state-of-the-art deep learning models tailored for analysis of familial data. The study highlighted 80 high-risk genes (out of > 1200 genes) and narrowed down on a group of 8 genes circulating in 7 out of 12 families in the study. These genes are involved in a cellular organelle called the peroxisome and play a role in fatty acids metabolism. We show that  these genes significantly affect breast cancer survival and use 3-dimensional protein structural analysis to illustrate the effect of some of the variants on protein structure. These provide strong evidence of the peroxisome involvement in breast cancer predisposition and pathogenicity, and provide potential targets for patient screening and targeted therapies.

04 Nov

Posted at 20:54h in Author Interviews, Ovarian Cancer
MedicalResearch.com Interview with: [caption id="attachment_64543" align="alignleft" width="114"]Alessia Baccarini, PhD Assistant Professor Dept. of Immunology and Immunotherapy (DII) Icahn School of Medicine at Mount Sinai New York, New York 10029 Dr .Baccarini[/caption] Alessia Baccarini, PhD Assistant Professor Dept. of Immunology and Immunotherapy (DII) Icahn School of Medicine at Mount Sinai New York, New York 10029 MedicalResearch.com: What is the background for this study? Response: Ovarian cancer is characterized by a complex tumor microenvironment (TME) that significantly contributes to resistance against immunotherapy, particularly immune checkpoint blockade (ICB) therapies like anti-PD-1. Understanding the extracellular signals—such as cytokines and chemokines—that ovarian cancer cells utilize to create an immunosuppressive TME is critical for improving treatment outcomes. Our research focuses on elucidating how these signaling factors contribute to tumor growth and immune evasion. We utilized a novel genomic functional approach called Perturb-map to study intratumoral heterogeneity (ITH) in ovarian cancer within a mouse model, allowing us to investigate the communication between ovarian cancer cells and immune cells. 

01 Nov

Posted at 21:48h in Author Interviews, Cancer Research, Leukemia, Stem Cells
MedicalResearch.com Interview with: [caption id="attachment_64480" align="alignleft" width="130"]Eirini Papapetrou, MD, PhDProfessor of Oncological Sciences Professor of Medicine, Hematology and Medical Oncology Director, Center for Advancement of Blood Cancer Therapies Co-Director, Stem Cell Engineering Core Icahn School of Medicine at Mount Sinai New York, NY 10029 Dr. Papapetrou[/caption] Eirini Papapetrou, MD, PhD Professor of Oncological Sciences Professor of Medicine, Hematology and Medical Oncology Director, Center for Advancement of Blood Cancer Therapies Co-Director, Stem Cell Engineering Core Icahn School of Medicine at Mount Sinai New York, NY 10029   MedicalResearch.com: What is the background for this study? What are the main findings? Response: RAS in the most commonly mutated oncogene in human cancers. Particularly in acute myeloid leukemia, about one third of cases have RAS mutations. We set out to understand the role of these mutations in the development of leukemia and in response to treatment. We found that RAS mutations happen late in the course of the disease as progression mutations because they are acquired by more mature leukemic cells coming from preexisting leukemia stem cells (LSCs). Importantly, these more mature cells, upon acquisition of RAS mutations, become leukemia stem cells (LSCs) with different properties than the previous LSCs. Most critically, they develop resistance to a recently FDA-approved drug for the treatment of leukemia, venetoclax (VEN). In addition, these RAS-mutated LSCs give rise to leukemia cells with monocytic differentiation. Both RAS mutations and monocytic differentiation of AML have previously been associated with VEN resistance in clinical studies. We show that it is the RAS mutations that cause both the monocytic differentiation and the VEN resistance. Thus, poor patient outcomes after VEN therapy are driven by RAS mutations and not by monocytic disease. 

31 Oct

Posted at 22:15h in Author Interviews, Health Care Systems, JAMA, Pharmacology, University of Pittsburgh
MedicalResearch.com Interview with: [caption id="attachment_64457" align="alignleft" width="200"]Dr. Katie Suda Dr. Suda[/caption] Katie J. Suda, PharmD, M.S., FCCP Professor of medicine with tenure Associate Director, Center for Pharmaceutical Policy and Prescribing University of Pittsburgh School of Medicine MedicalResearch.com: What is the background for this study? Response: Our pharmaceutical supply chain is global where the manufacturing process for one drug may occur in multiple countries. Sometimes there are breakdowns in the pharmaceutical supply chain which may threaten access to medicines. Breakdowns in the supply chain occur for medicines manufactured in the U.S. and by international partners. While breakdowns in the supply chain occur for hundreds of drugs each year, not all result in a decrease in available supply (a “drug shortage”) because of action taken by manufacturers, pharmacies and drug regulators (e.g., the U.S. Food and Drug Administration [FDA]). Drug shortages are a critical concern to public health as pharmacies, clinicians, and patients struggle to identify safe and effective alternatives. In addition, drug shortages have been associated with adverse patient outcomes and medication safety events. Recently, drug shortages have gotten worse with shortages occurring with increasing frequency and lasting longer. There has also been a shift in the types of medicines in shortage from drugs primarily used in hospitals, such as injectables, to oral medicines frequently used to manage outpatient conditions. Countries have different regulatory authority and policy which may impact how drug supply chain breakdowns result in drug shortages. We wanted to know if there are differences between the U.S. and Canada in the frequency that national drug shortages occur after supply chain breakdowns are reported in both countries. Canada is a good comparator to the U.S. because Canada has similar drug regulatory standards and manufacturing inspections. Prescription drug coverage is also similar for the two countries where half of prescriptions are reimbursed through public insurance and half through private insurance and out-of-pocket.